Literature DB >> 14711764

Obstructed labour.

J P Neilson1, T Lavender, S Quenby, S Wray.   

Abstract

Obstructed labour is an important cause of maternal deaths in communities in which undernutrition in childhood is common resulting in small pelves in women, and in which there is no easy access to functioning health facilities with the capability of carrying out operative deliveries. Obstructed labour also causes significant maternal morbidity in the short term (notably infection) and long term (notably obstetric fistulas). Fetal death from asphyxia is also common. There are differences in the behaviour of the uterus during obstructed labour, depending on whether the woman has delivered previously. The pattern in primigravid women (typically diminishing contractility with risk of infection and fistula) may result from tissue acidosis, whereas in parous women, contractility may be maintained with the risk of uterine rupture. Ultimately, tackling the problem of obstructed labour will require universal adequate nutritional intake from childhood and the ability to access adequately equipped and staffed clinical facilities when problems arise in labour. These seem still rather distant aspirations. In the meantime, strategies should be implemented to encourage early recognition of prolonged labour and appropriate clinical responses. The sequelae of obstructed labour can be an enormous source of human misery and the prevention of obstetric fistulas, and skilled treatment if they do occur, are important priorities in regions where obstructed labour is still common.

Entities:  

Mesh:

Year:  2003        PMID: 14711764     DOI: 10.1093/bmb/ldg018

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  44 in total

Review 1.  Antispasmodics for labour.

Authors:  Anke C Rohwer; Oswell Khondowe; Taryn Young
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

2.  Covariation between human pelvis shape, stature, and head size alleviates the obstetric dilemma.

Authors:  Barbara Fischer; Philipp Mitteroecker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

3.  Comparison of two WHO partographs: a one year randomized controlled trial.

Authors:  Swamy Mallaiah Kenchaveeriah; Kamal Prakash Patil; Tania Gurudeep Singh
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-03-01

4.  Cliff-edge model of obstetric selection in humans.

Authors:  Philipp Mitteroecker; Simon M Huttegger; Barbara Fischer; Mihaela Pavlicev
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-05       Impact factor: 11.205

Review 5.  Overcoming phase 1 delays: the critical component of obstetric fistula prevention programs in resource-poor countries.

Authors:  L Lewis Wall
Journal:  BMC Pregnancy Childbirth       Date:  2012-07-18       Impact factor: 3.007

6.  Costs of surgical procedures in Indian hospitals.

Authors:  Susmita Chatterjee; Ramanan Laxminarayan
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

7.  Women-focused development intervention reduces delays in accessing emergency obstetric care in urban slums in Bangladesh: a cross-sectional study.

Authors:  Shamsun Nahar; Morsheda Banu; Hashima E Nasreen
Journal:  BMC Pregnancy Childbirth       Date:  2011-01-30       Impact factor: 3.007

Review 8.  Effect of partogram use on outcomes for women in spontaneous labour at term.

Authors:  Tina Lavender; Anna Hart; Rebecca M D Smyth
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

9.  Uterine rupture in a teaching hospital in Mbarara, western Uganda, unmatched case- control study.

Authors:  Peter K Mukasa; Jerome Kabakyenga; Jude K Senkungu; Joseph Ngonzi; Monica Kyalimpa; Van J Roosmalen
Journal:  Reprod Health       Date:  2013-05-29       Impact factor: 3.223

10.  A comparison of the contractile properties of myometrium from singleton and twin pregnancies.

Authors:  Peter Turton; Sarah Arrowsmith; Jonathan Prescott; Celia Ballard; Leanne Bricker; James Neilson; Susan Wray
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.